LRMR
Price
$2.00
Change
-$0.19 (-8.64%)
Updated
Apr 3, 02:48 PM (EDT)
Capitalization
140.86M
35 days until earnings call
OCGN
Price
$0.64
Change
-$0.05 (-7.25%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
201.2M
29 days until earnings call
Ad is loading...

LRMR vs OCGN

Header iconLRMR vs OCGN Comparison
Open Charts LRMR vs OCGNBanner chart's image
Larimar Therapeutics
Price$2.00
Change-$0.19 (-8.64%)
Volume$2.9K
Capitalization140.86M
Ocugen
Price$0.64
Change-$0.05 (-7.25%)
Volume$66.74K
Capitalization201.2M
LRMR vs OCGN Comparison Chart
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. OCGN commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and OCGN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (LRMR: $2.20 vs. OCGN: $0.69)
Brand notoriety: LRMR and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 214% vs. OCGN: 94%
Market capitalization -- LRMR: $140.86M vs. OCGN: $201.2M
LRMR [@Biotechnology] is valued at $140.86M. OCGN’s [@Biotechnology] market capitalization is $201.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, LRMR is a better buy in the long-term than OCGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 4 TA indicator(s) are bullish while OCGN’s TA Score has 5 bullish TA indicator(s).

  • LRMR’s TA Score: 4 bullish, 3 bearish.
  • OCGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than OCGN.

Price Growth

LRMR (@Biotechnology) experienced а -2.22% price change this week, while OCGN (@Biotechnology) price change was -6.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.22%. For the same industry, the average monthly price growth was -10.33%, and the average quarterly price growth was -14.34%.

Reported Earning Dates

LRMR is expected to report earnings on May 08, 2025.

OCGN is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (-8.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCGN($201M) has a higher market cap than LRMR($141M). OCGN YTD gains are higher at: -14.410 vs. LRMR (-43.152). OCGN has higher annual earnings (EBITDA): -52.79M vs. LRMR (-73.44M). LRMR has more cash in the bank: 204M vs. OCGN (58.5M). LRMR has less debt than OCGN: LRMR (5.36M) vs OCGN (32.5M). OCGN has higher revenues than LRMR: OCGN (4.06M) vs LRMR (0).
LRMROCGNLRMR / OCGN
Capitalization141M201M70%
EBITDA-73.44M-52.79M139%
Gain YTD-43.152-14.410299%
P/E RatioN/AN/A-
Revenue04.06M-
Total Cash204M58.5M349%
Total Debt5.36M32.5M16%
FUNDAMENTALS RATINGS
LRMR vs OCGN: Fundamental Ratings
LRMR
OCGN
OUTLOOK RATING
1..100
6716
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9683
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (19) in the null industry is somewhat better than the same rating for OCGN (65). This means that LRMR’s stock grew somewhat faster than OCGN’s over the last 12 months.

OCGN's Profit vs Risk Rating (96) in the null industry is in the same range as LRMR (100). This means that OCGN’s stock grew similarly to LRMR’s over the last 12 months.

OCGN's SMR Rating (99) in the null industry is in the same range as LRMR (100). This means that OCGN’s stock grew similarly to LRMR’s over the last 12 months.

OCGN's Price Growth Rating (83) in the null industry is in the same range as LRMR (96). This means that OCGN’s stock grew similarly to LRMR’s over the last 12 months.

OCGN's P/E Growth Rating (100) in the null industry is in the same range as LRMR (100). This means that OCGN’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMROCGN
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 30 days ago
87%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX44.61N/A
N/A
Tocqueville
FLCSX53.52N/A
N/A
Fidelity Large Cap Stock
MUIGX15.52N/A
N/A
Nationwide BNY Mellon Dyn US Core R6
SSCPX6.24N/A
N/A
Saratoga Small Capitalization I
GSMVX15.56N/A
N/A
Goldman Sachs Small/Mid Cap Value Instl

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+10.00%
SVRA - LRMR
45%
Loosely correlated
+5.24%
ACLX - LRMR
42%
Loosely correlated
+10.76%
IMNM - LRMR
41%
Loosely correlated
+7.19%
ERAS - LRMR
41%
Loosely correlated
+4.56%
IDYA - LRMR
41%
Loosely correlated
+10.70%
More